BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 17420344)

  • 21. Predictive capacity of a multimarker strategy to determine short-term mortality in patients attending a hospital emergency Department for acute heart failure. BIO-EAHFE study.
    Herrero-Puente P; Prieto-García B; García-García M; Jacob J; Martín-Sánchez FJ; Pascual-Figal D; Bueno H; Gil V; Llorens P; Vázquez-Alvarez J; Romero-Pareja R; Sanchez-Gonzalez M; Miró Ò
    Clin Chim Acta; 2017 Mar; 466():22-30. PubMed ID: 28069402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction.
    Khan SQ; Quinn P; Davies JE; Ng LL
    Heart; 2008 Jan; 94(1):40-3. PubMed ID: 17488769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP.
    Dhillon OS; Narayan HK; Quinn PA; Squire IB; Davies JE; Ng LL
    Am Heart J; 2011 Jun; 161(6):1163-70. PubMed ID: 21641364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myeloperoxidase aids prognostication together with N-terminal pro-B-type natriuretic peptide in high-risk patients with acute ST elevation myocardial infarction.
    Khan SQ; Kelly D; Quinn P; Davies JE; Ng LL
    Heart; 2007 Jul; 93(7):826-31. PubMed ID: 17194712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure.
    Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
    JAMA; 2011 May; 305(20):2088-95. PubMed ID: 21610241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure.
    Tentzeris I; Jarai R; Farhan S; Perkmann T; Schwarz MA; Jakl G; Wojta J; Huber K
    Eur J Heart Fail; 2011 Jul; 13(7):726-33. PubMed ID: 21616953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiotrophin-1 predicts death or heart failure following acute myocardial infarction.
    Khan SQ; Kelly D; Quinn P; Davies JE; Ng LL
    J Card Fail; 2006 Oct; 12(8):635-40. PubMed ID: 17045183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Copeptin and NT-proBNP for prediction of all-cause and cardiovascular death in ischemic stroke.
    Tu WJ; Ma GZ; Ni Y; Hu XS; Luo DZ; Zeng XW; Liu Q; Xu T; Yu L; Wu B
    Neurology; 2017 May; 88(20):1899-1905. PubMed ID: 28424274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copeptin predicts 10-year all-cause mortality in community patients: a 10-year prospective cohort study.
    Odermatt J; Bolliger R; Hersberger L; Ottiger M; Christ-Crain M; Briel M; Bucher HC; Mueller B; Schuetz P
    Clin Chem Lab Med; 2016 Oct; 54(10):1681-90. PubMed ID: 27171391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of plasma copeptin levels and early diagnosis of acute myocardial infarction compared with troponin-T.
    Piyanuttapull S
    J Med Assoc Thai; 2013 Jan; 96(1):13-9. PubMed ID: 23720972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Copeptin as a biomarker in heart failure.
    Balling L; Gustafsson F
    Biomark Med; 2014; 8(6):841-54. PubMed ID: 25224940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD.
    Stolz D; Christ-Crain M; Morgenthaler NG; Leuppi J; Miedinger D; Bingisser R; Müller C; Struck J; Müller B; Tamm M
    Chest; 2007 Apr; 131(4):1058-67. PubMed ID: 17426210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndrome.
    Dhillon OS; Khan SQ; Narayan HK; Ng KH; Mohammed N; Quinn PA; Squire IB; Davies JE; Ng LL
    Clin Sci (Lond); 2009 Nov; 118(4):249-57. PubMed ID: 19583569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction.
    Potocki M; Reichlin T; Thalmann S; Zellweger C; Twerenbold R; Reiter M; Steuer S; Bassetti S; Drexler B; Stelzig C; Freese M; Winkler K; Haaf P; Balmelli C; Hochholzer W; Osswald S; Mueller C
    Heart; 2012 Apr; 98(7):558-65. PubMed ID: 22337952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
    O'Malley RG; Bonaca MP; Scirica BM; Murphy SA; Jarolim P; Sabatine MS; Braunwald E; Morrow DA
    J Am Coll Cardiol; 2014 Apr; 63(16):1644-53. PubMed ID: 24530676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Copeptin and insulin-like growth factor binding protein-1 during follow-up after an acute myocardial infarction in patients with type 2 diabetes: A report from the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction 2 cohort.
    Smáradóttir MI; Catrina SB; Brismar K; Norhammar A; Gyberg V; Mellbin LG
    Diab Vasc Dis Res; 2019 Jan; 16(1):22-27. PubMed ID: 30309264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of copeptin and high-sensitive cardiac troponin T for diagnosis and prognosis in patients with diabetes mellitus and suspected acute myocardial infarction.
    Zellweger C; Wildi K; Twerenbold R; Reichlin T; Naduvilekoot A; Neuhaus JD; Balmelli C; Gabutti M; Al Afify A; Ballarino P; Jäger C; Druey S; Hillinger P; Haaf P; Vilaplana C; Darbouret B; Ebmeyer S; Rubini Gimenez M; Moehring B; Osswald S; Mueller C
    Int J Cardiol; 2015; 190():190-7. PubMed ID: 25920022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction.
    Talwar S; Squire IB; Downie PF; Mccullough AM; Campton MC; Davies JE; Barnett DB; Ng LL
    Eur Heart J; 2000 Sep; 21(18):1514-21. PubMed ID: 10973765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk stratification of normotensive pulmonary embolism: prognostic impact of copeptin.
    Hellenkamp K; Schwung J; Rossmann H; Kaeberich A; Wachter R; Hasenfuß G; Konstantinides S; Lankeit M
    Eur Respir J; 2015 Dec; 46(6):1701-10. PubMed ID: 26493800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incremental value of copeptin for rapid rule out of acute myocardial infarction.
    Reichlin T; Hochholzer W; Stelzig C; Laule K; Freidank H; Morgenthaler NG; Bergmann A; Potocki M; Noveanu M; Breidthardt T; Christ A; Boldanova T; Merki R; Schaub N; Bingisser R; Christ M; Mueller C
    J Am Coll Cardiol; 2009 Jun; 54(1):60-8. PubMed ID: 19555842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.